Dr. Ahmad Tarhini, MD
book an appointment
Dr. Ahmad Tarhini, MD
Medical Oncology
Dr. Ahmad Tarhini, MD is a medical oncologist in Tampa, FL. He is affiliated with Moffitt Cancer Center Magnolia Campus. He is accepting new patients and telehealth appointments.
Locations
Moffitt Cancer Center, Magnolia Campus
At a Glance
- Area of Expertise • Dr. Tarhini specializes in the area of Medical Oncology. See board certifications
- Explains Conditions Well • Patients said this doctor explains conditions well. See reviews
- Offers Telehealth • This doctor offers telehealth appointments. Call the office to schedule an appointment.
More Oncology Specialists at Moffitt Cancer Center
Experience Check
Search for experience in a specific area
Dr. Tarhini's Reviews
Likelihood to recommend Dr. Tarhini
4.0
| 5 Star | 67% | 67% |
| 4 Star | 0% | 0% |
| 3 Star | 0% | 0% |
| 2 Star | 33% | 33% |
| 1 Star | 0% | 0% |
Is this your profile?
Respond to reviews, add information, and reach more patients. Claiming is free and only takes a minute.
Claim your profileOverall Patient Satisfaction
Likelihood of recommending Dr. Tarhini to family and friends is 4 out of 5
Insurance Check
Search for your insurance carrier and choose your plan type
About Me
care philosophy
Ahmad Tarhini, MD, PhD is an internationally recognized physician and leading researcher in Melanoma, Skin Cancers and Immuno-Oncology. Dr Tarhini is a Tenured Senior Member in the Moffitt Cancer Center and Research Institute Departments of Cutaneous...read morebiography
Ahmad Tarhini, MD, PhD is an internationally recognized physician and leading researcher in Melanoma, Skin Cancers and Immuno-Oncology. Dr. Tarhini is a Tenured Senior MeMedical Oncology
*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Healthgrades receives board action history for physicians and physician assistants. The information displayed here is sourced from independent information providers, such as state board websites, and may not be the most up-to-date information. Healthgrades makes no representations with respect to the accuracy of any information provided here and assumes no responsibility or liability for such information.
Learn more about medical license public record checkCetuximab for Immunotherapy-Refractory/Ineligible Cutaneous Squamous Cell Carcinoma, 2023-06-14
A Tumor and Immune-Related Micro-RNA Signature Predicts Relapse-Free Survival of Melanoma Patients Treated with Ipilimumab, 2023-05-03
Adjuvant Therapy for High-Risk Melanoma: An In-Depth Examination of the State of the Field, 2023-08-16
A bioinformatics tool for identifying intratumoral microbes from the ORIEN dataset, 2023-05-24
Sentinel Lymph Node Gene Expression Signature Predicts Recurrence-Free Survival in Cutaneous Melanoma, 2022-10-11
Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to males, 2022-06-03
Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review, 2023-04-29
Leptomeningeal Disease (LMD) in Patients with Melanoma Metastases, 2023-03-21
Leave a review
How was your experience with Dr. Tarhini?